REINFORCING SUBJECTIVE EFFECTS OF (+ -) 3,4-METHYLENEDIOXYMETHAMPHETAMINE (ECSTASY) MAY BE SEPARABLE FROM ITS NEUROTOXIC ACTIONS - CLINICAL-EVIDENCE/

Citation
Ud. Mccann et Ga. Ricaurte, REINFORCING SUBJECTIVE EFFECTS OF (+ -) 3,4-METHYLENEDIOXYMETHAMPHETAMINE (ECSTASY) MAY BE SEPARABLE FROM ITS NEUROTOXIC ACTIONS - CLINICAL-EVIDENCE/, Journal of clinical psychopharmacology, 13(3), 1993, pp. 214-217
Citations number
25
Categorie Soggetti
Pharmacology & Pharmacy",Psychiatry
ISSN journal
02710749
Volume
13
Issue
3
Year of publication
1993
Pages
214 - 217
Database
ISI
SICI code
0271-0749(1993)13:3<214:RSEO(->2.0.ZU;2-N
Abstract
(+/-)3,4-Methylenedioxymethamphetamine (MDMA), a synthetic amphetamine derivative used recreationally by humans, damages brain serotonin neu rons in experimental animals. In preclinical studies, serotonin reupta ke inhibitors block MDMA-induced serotonin release; they also block MD MA neurotoxicity. Whether serotonin reuptake inhibitors also block MDM A's psychoactive effects in humans has not been established. Reported herein are four individuals who describe their experiences after inges ting fluoxetine, a potent and selective serotonin reuptake inhibitor, before MDMA ingestion. Their reports indicate that fluoxetine does not block MDMA's reinforcing subjective effects and raise the possibility that MDMA's psychoactive effects may be separable from its neurotoxic actions.